SciELO - Scientific Electronic Library Online

 
vol.38 issue4Screening of Metarhizium spp. strains for anticancer indolizidine alkaloid production and its rapid detection by MS analysis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

Share


Brazilian Journal of Microbiology

Print version ISSN 1517-8382

Braz. J. Microbiol. vol.38 no.4 São Paulo Oct./Dec. 2007

http://dx.doi.org/10.1590/S1517-83822007000400036 

INDUSTRIAL MICROBIOLOGY

 

Antimicrobial properties of sclerotiorin, isocHromophilone VI and pencolide, metabolites from a Brazilian cerrado isolate of Penicillium sclerotiorum van Beyma

 

Atividade antimicrobiana de esclerotiorina, isocromofilona VI e pencolídeo, metabólitos secundários de Penicillium sclerotiorum van Beyma isolado de solo do cerrado brasileiro

 

 

Esther M.F. Lucas; Mateus C. Monteiro de Castro; Jacqueline A. Takahashi*

Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil

 

 


ABSTRACT

As a part of a research program that aims to identify antibacterial and antifungal substances from fungus specimen of Brazilian's cerrado soil samples, Penicillium sclerotiorum was identified as a source of secondary metabolites possessing antibiotic activities. This microorganism was cultured in a liquid medium rich in glucose for fifteen days. The resulting ethyl acetate extract was chemically fractionated leading to the isolation of three metabolites pencolide, sclerotiorin and isochromophilone VI. The antimicrobial disc assay activity of these substances towards Candida albicans, Streptomyces pyogenes, Staphylococcus aureus, Salmonella typhimurium and Escherichia coli was performed. Minimum inhibitory concentration (MIC) of the compounds was determined. All compounds showed distinguished antimicrobial activities.

Key-words: sclerotiorin, isocromophilone VI, pencolide, antibiotics, Penicillium sclerotiorum


RESUMO

Como parte de um programa de pesquisa visando a identificação de substâncias antibacterianas e antifúngicas a partir de espécies fúngicas isoladas de solo do cerrado, foi estudado o fungo Penicillium sclerotiorum van Beyma. Este microrganismo foi cultivado em meio líquido rico em glicose e, após extração com acetato de etila, este foi quimicamente fracionado levando ao isolamento de três metabólitos pencolídeo, esclerotiorina e isocromofilona VI. A atividade destas três substâncias, por meio de teste de difusão em discos, contra Candida albicans, Streptomyces pyogenes, Staphylococcus aureus, Salmonella typhimurium e Escherichia coli foi avaliada. A concentração inibitória mínina das substâncias ativas foi determinada.

Palavras-chave: esclerotiorina, isocromofilona VI, oencolídeo, antibióticos, Penicillium sclerotiorum


 

 

INTRODUCTION

The discovery of penicillin and further development of antibiotic therapy was one of the most important achievements of last century. Novel antibiotics are nevertheless a real modern need, mainly for emergent economy countries where infectious sickness still causes a considerable number of deaths. The increasing amount of people who have imunossupressing or some metabolic diseases, the growing bacterial resistance phenomenon, the collateral effects of some antimicrobial drugs and the high cost of a complete and effective antimicrobial program contribute to this necessity.

Concerning that fungus versus fungus and fungus versus bacteria competition occurs based on chemical mediators, the research on new fungal metabolites that can became novel antibiotics prototypes is a very promising field (1). Fungi have proved to be capable of biosynthesizing secondary metabolites bearing conspicuous structural diversity, which could be further enlarged by structure modification. Among 20 of the most commonly prescribed medications, six are from fungal origin (2).

Brazilian cerrado transition biome holds a soil poor in nutritional compounds. To survive in hostile habitats it is expected that fungus isolated from cerrado transition areas should develop a sophisticated metabolism, most probably molecules of odd chemical structures possessing interesting biological properties.

Those facts motivated the development of a research program which aims to perform the isolation of antimicrobial substances from Brazilian's cerrado soil fungi. As a part of this program, three active compounds, pencolide (I) and the azaphilones sclerotiorin (II) and isochromophilone VI (III) were detected to be the active metabolites produced by P. sclerotiorum van Beyma (Fig. 1), one of the species isolated on this project.

 

 

Sclerotiorin (II) was the first fungal metabolite isolated from Penicillium sclerotiorum by Curtin and Reilly (3) and its structure was established by Dean in 1959 (4). Isochromophilone VI (III) was the first naturally occurring nitrogen-containing derivative from an azaphilone, isolated in 1995 (5), related to inhibit of cholesteryl ester transfer protein by two groups (6,7). To sclerotiorin (II) there were related activities as endothelin receptor binding (8), inhibition of Grb-2-Sch interaction blocking the oncogenic RAS signal (9), and inhibition of lipase leading to its patenting in Japan to prepare anti-acne creams and anti obesity biscuits (10). Sclerotiorin also inhibits aldose reductase, an enzyme associated to diabetics' complications such as cataract, neuropathy and nephropathy (11) and it has antibacterial activity in diffusion disc antibiotic test against Micrococcus luteus, Bacillus cereus, Bacillus subtilis, Klebisiella pneumoniae, Escherichia coli, Salmonella typhimurium and Lysteria monocytogenes (11). Pencolide (I) was also isolated from P. sclerotiorum and its structure was determinate chemically by Birkinshaw and co-workers (12) and spectroscopically by Sutherland (13). There were not found reports on pencolide biological activities.

The antimicrobial activity of substances I-III was evaluated against Candida albicans, Streptomyces pyogenes, Staphylococcus aureus, Salmonella typhimurium and Escherichia coli by qualitative disc test assay and the minimum inhibitory concentration (MIC) for antimicrobial activity was established.

 

MATERIALS AND METHODS

Reagents and equipments

Culture medium components were purchased from Biobrás (Montes Claros, Brazil). Solvents and eluants were purchased from Grupo Química (São Paulo, Brazil). Blanc and positive control discs were obtained from CECON (São Paulo, Brazil). Column grade silicagel (article 7734) and thin layer chromatography silicagel (article 7731) were purchased from Merck (Darmstadt, Germany). Vortex apparatus used was an AP 56-Phoenix (Araraquara, Brazil). Melting points were determined on a Mettler FP80HT apparatus and are uncorrected. Infrared spectra were obtained on a Spectrum One FT IR Spectrometer (Perkin-Elmer). 1H and 13C Nuclear Magnetic Resonance spectra were obtained from a Bruker DRX-400 and DRX 200 Advance. Mass spectra were obtained from a gas chromatographer HP5989A series II, coupled to a mass spectrometer 5989A HP, 70 ev using a methyl silicone fusioned silica column (30 x 0.2 mm).

Microorganisms

P. sclerotiorum was isolated from a soil sample collected at Serra do Cipó National Park Minas Gerais, a typical Brazilian region of cerrado transition. Small portions of soil were serially diluted and plated on solid media containing (g/l): KH2PO4 (1.0), MgSO4.7H2O (0.5), Peptone (5.0), Dextrose (10.0), Rose Bengal (0.033). Upon growth, individual colonies were transferred to other plates successively until the isolation of pure cultures. P. sclerotiorum was identified by microscopic observation of micro-structure (14).The fungal strains were maintained on potato dextrose agar (PDA) and refrigerated at 7ºC. There were used the following American Type Culture Collection (ATCC) strains: Candida albicans ATCC 18804, Streptomyces pyogenes ATCC 19615, Staphylococcus aureus ATCC 29213, Salmonella typhimurium ATCC 14028 and Escherichia coli ATCC 25922.

Metabolites production

For metabolites production, P. sclerotiorum was inoculated into seven conical flasks, containing each, one liter of aqueous medium containing (g/l): Dextrose (20.0), Peptone (5.0), KH2PO4 (1.0), MgSO4.7H2O (0.5) and NaCl (5.0). The growth took place for fifteen days, after which ethyl acetate was added to stop the growth.

Extraction of metabolites

The mycelium was separated from the culture broth by filtration. Both mycelium and broth of six conical flasks were extracted three times with 300 ml of ethyl acetate each. The resulting layers were combined and the solvent was eliminated by evaporation by using a rotator vacuum distilling apparatus leading to 3.1 g of crude extract.

Isolation of pencolide (I) and isochromophilone VI (III)

This extract was fractionated by chromatography in a silica gel column (6.0 x 25.0 cm) using, as eluants, hexane, ethyl acetate and methanol 100% and in mixtures of growing polarities leading to 51 fractions, which were combined in 24 groups, according to thin layer chromatography profiles. Fractions 24-25, eluted by a mixture of hexane and ethyl acetate 1:3 were joined leading to 569 mg of a brown solid that, after being washed with ethyl ether lead to 33.1 mg of a white solid that was identified as pencolide (I). Fractions 33-42 were also combined, leading to the isolation of 29.7 mg of a solid that was rechromatographed on a silica gel column (2.0 x 5.5 cm) eluted as before. Fractions 34-51, eluted by a mixture of hexane and ethyl acetate 1:1 gave 32.9 mg of a red solid that was isolated and identified as isochromophilone VI (III).

Isolation of sclerotiorin (II)

To the culture medium of one conical flask 300 ml of ethyl acetate were added and this system was left standing at room temperature for 24 hours. After this time, the natural evaporation of ethyl acetate lead to precipitation of a dark orange solid, that was collected and washed successively with ethyl alcohol at room temperature then under heating and with heated hexane, leading to 7.6 mg of an orange solid that was identified as sclerotiorin (II).

Identification of the substances

Identification of the substances was performed by the comparison of the measured melting points and spectral data with those described on the literature (7, 12, 13 and 15).

Antimicrobial activity assay

2.0 mg of each substance were solubilized in 1 ml of chloroform. 50 ml of each solution were quantitatively loaded on a paper to make a final concentration of 100 ml/disc. The solvent was removed by dry air. The test plates were prepared with 7.5 ml of Number 1 Antibiotic Medium and sterilized in autoclave by 15 minutes at 121ºC. 0.4 ml of the diluted bacteria inoculum (500 ml of stock culture in 2.0 ml of BHI let 18 h at 37ºC) were transferred to 4.5 ml of saline solution) and homogenized using a vortex. A negative control was set using a disc impregnated with 50 ml of chloroform, and chloramphenicol (30 mg/disc) was used as positive control of antibacterial test; to antifungal test miconazol (50 mg/disc) was used. Experiments were run in duplicate. The result was ridden after incubation by 24 hours at 37ºC.

Minimum inhibitory concentration test

2.05 mg of each test substance were dissolved in 2.0 ml of dimetylformamide. The minimum inhibitory concentration test of substances 1-3 were determined by series dilution in BHI on the concentrations of 512, 256, 128, 64, 32, 16, 9, 4, 2 and 1 mg/ml. Aliquots of 100 ml of the bacteria suspensions, which had their concentrations adjusted according to 0.5 McFarland scale (1.5 x 108 CFU/ml), were added to tubes containing 1 ml of BHI medium plus the test substances. Test tubes were incubated by 24 hours, at 37ºC, and the minimum inhibitory concentration was determined as the lowest concentration of substance that showed no haze. Both assays were carried out in duplicate.

Survival microorganism test

50 ml of each end point test tube solution were transferred to a tube containing 2.0 ml of BHI and incubated by 24 hours, at 37ºC. When no haze was observed, the effect of the substance was considered to be bactericidal and, those ones where haze was observed, a bacteriostatic effect of the substance was characterized.

 

RESULTS AND DISCUSSION

From all fungi isolated from Serra do Cipó National Park soil, P. sclerotiorum showed to be one of the most active isolates. Large scale liquid culture of this species led to the isolation of pencolide (I), sclerotiorin (II) and isochromophilone VI (III). As sclerotiorin has been previously reported to be an antibacterial agent (11), compounds I and III were screened by disc diffusion test in order to observe wheatear they also contributed for the extract bioactivity. Sclerotiorin was included in the bioactivity study in order to broader its antibacterial screening. In the disc test, compounds I and II showed inhibition zones towards all Gram positive and Gram negative bacteria tested (S. pyogenes, S. aureus, S. typhimurium and E. coli) and towards the yeast C. albicans. Isochromophilone VI (III) showed inhibition zone only against S. aureus. The values of inhibition zones are shown on Table 1. Despite its simple structure compared to sclerotiorin and isochromophilone VI, pencolide showed to be most active tested metabolite of P. sclerotiorum. The inhibition zone values of all compounds are lower than the values observed for the positive controls. However, considering the low diffusion rate of non-polar compounds in agar, such results are still promising.

For a more quantitative comparison of potential of compounds I-III as new leads for the development of antibiotic agents, minimum inhibitory concentration of all compounds was evaluated. Results obtained for sclerotiorin (II) against E. coli and S. typhimurium are in accordance with the activity reported for this compound by Chidananda and co-workers (11), but, in our experiments, compound II showed activity also against S. aureus, probably due to the use of a different bacterial strain (16). The MIC and survival test results confirm the activity of sclerotiorin (II) against S. aureus (Table 2) in our screening protocol.

Interestingly, isochromophilone VI (III) did not show activity in the disc diffusion assay against S. pyogenes, S. typhimurium, E. coli and C. albicans, but presented activity at low doses (64 mg) in the MIC tests. This is indeed a good indication that disc diffusion assay should be considered only a very preliminary screening test, with serious limitation when organic non polar compounds are screened. Several factors besides diffusion rate in solid agar media can hold up linearity between inhibition zone diameter and antibiotic activity of a given compound, for example, amount of substrate loaded in the disc, precipitation of the compound on the disc after solvent evaporation, residual solvent content in the disc (especially when non volatile solvents such as dimethylsulphoxide are used), full adherence of the paper disc on the agar surface and size of the inoculum used in the experiment. Upon a careful observation of such possible interferences, disc diffusion assay is still a useful tool for preliminary screening on natural products bioprospecting programs.

When the kind of bacterial growth activity presented by pencolide, sclerotiorin and Isochromophilone VI was studied, it was found that they possess bacteriostatic activity against all Gram positive and Gram negative bacteria tested, suggesting a possible broad activity spectrum. The low MIC values obtained for isocromophilone VI suggests a more effective activity of this substance against S. pyogenes and S. typhimurium than the other two compounds.

The fungicidal activity against C. albicans was observed for all tested substances. This result is quite interesting due to the increasing problems faced by patients bearing C. albicans recurrent infections. This yeast is also the main causative agent of a frequent oropharyngeal candidiasis in immune deficient patients (17) and it is pretty difficult to find substances active against C. albicans bearing selective toxicity, due the resemblance between mammalian and fungal cells. The existence of a Japanese patent on the use of extracts rich in sclerotiorin in food preparations (10) points out that the use of this substance to combat human fungal infections may not cause toxic collateral effects.

 

ACKNOWLEDGEMENTS

The authors thank International Foundation for Science (IFS, grants F/3564-1 and 2), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Process 307846/2006-7) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG, grant CEX 1088/05) for financial support.

 

REFERENCES

1. Newman, D.J.; Cragg, G.M. (2007) Natural Products as Sources of New Drugs over the Last 25 Years. J. Nat. Prod., 70(3), 461-477.         [ Links ]

2. Furtado, N.A.J.C.; Fonseca, M.J.V.; Bastos, J. (2005). The potential of an Aspergillus fumigatus Brazilian strain to produce antimicrobial secondary metabolites. Braz. J. Microbiol., 36, 357-362.         [ Links ]

3. Curtin, T.M.; Reilly, J. (1940). Sclerotiorin, a chlorinated metabolic product of Penicillium sclerotiorum, Van Beyma. Nature, 3697, 335.         [ Links ]

4. Dean, F.M.; Staunton, J.; Waalley, W.B. (1959). The chemistry of fungi. Part XXXVI. A revised structure for sclerotiorin. J. Chem. Soc., 3004-3009.         [ Links ]

5. Wei, W-G.; Yao, Z-J. (2005). Synthesis studies toward Chloroalzaphilone and Vinylogouspyridones: Two common Natural product core structures. J. Org. Chem., 70, 4585-4590.         [ Links ]

6. Arai, N.; Shiomi, K.; Tomoda, H.; Tabata, N.; Yang, D.J.; Masuma, R.; Kawakubo, T.; Omura, S.J. (1995). Isocromophilones I-VI, inihibitors off acyl-CoA: cholesterol transferase produced by Penicillium multicolor FO-3216. The J. of Antib., 48(7), 696-702.         [ Links ]

7. Tomoda, H.; Matsushima, C.; Tabata, N.; Namatame I; Tanaka, H.; Bamberger M. J.; Arai H.; Fukazawa M.; Inoue K.; Omura, S. J. (1999). Stucture-specific inihibition of: cholesteryl ester transfer proteins by Azaphilones. The J.of Antib., 52(2), 160-170.         [ Links ]

8. Pairet, l.; Wrigley, S.K.; Chetland, I,; Reynolds, E.E.; Hayes, M.A.; Holloway, J.; Ainsworth, A.M.; Katzer, W.; Cheng, X-M.; Hupe, D.J.; Charlton, P.; Doherty, A.M. (1995). Azaphilones with endothelin receptor biding activity produced by Penicillium sclerotiorum: taxonomy, fermentation, isolation, structure elucidation and biological activity. The J. of Antib., 48(9), 913-922.         [ Links ]

9. Nam, J-Y.; Kwang-Hee, S.; Hyae-Kyeong K.; Mi-Young, H.; Sung-Uk, K.; Jung-Do, C.; Byoung-Mog, K. (2000). Sclerotiorin and Isocromophilone IV: inhibitors of Grb2Shc interaction, isolated from Penicillium multicolor F1753. J. Microbiol. Biotechnol., 10(4), 544-546.         [ Links ]

10. Negishi, Y.; Matsuo, N.; Miyadera, K.; Tanishima, M. (2000). Lipase inhibitors containing sclerotiorin. Jpn. Pat., 98-376263 19981224.         [ Links ]

11. Chidananda, C.; Rao, J.M.; Sattur, A.P. (2006). Sclerotiorin, from Penicillium frequentans, a potent inhibitor of aldose reductase. Biotechnol. Lett., 28, 1633-1636.         [ Links ]

12. Birkinshaw, J.H.; Kalyanpur, M.G.; Stickings, C.E. (1963). Studies in the biochemistry of micro-organisms. Biochem. J., 86, 237-243.         [ Links ]

13. Sutherland J.K. (1963). The proton-Magnetic-Resonance spectrum of pencolide. Biochem. J., 86, 243.         [ Links ]

14. Pitt, J. (2000). A Laboratory guide to common Penicillium species. Food Science, Australia, 197p.         [ Links ]

15. Michael, A.P.; Grace, E.J.; Kotiw, M.; Barrow, R.A. (2003). Isochromophilone XI, a novel GABA-containing metabolite isolated from a cultured fungus Penicillium sp. Aust. J. Chem., 56(1), 13-15.         [ Links ]

16. Indu, M.N.; Hatha, A.A.M.; Abiroshi, C.; Harsha, U.; Vivekanandan, G. (2006). Antimicrobial activity of some of the south-indian species against serotypes of Escherichia coli, salmonella, listeria monocitogenes and aeromonas hidrophila. Braz. J. Microbiol., 37, 153-158.         [ Links ]

17. Melo, N.R.; Vilela, M.M.S.; Junior, J.J.; Kamei, K.; Miayaji, K.F.; Nishimura, K.; Groeneveld, P.; Kelly, S.; Taguchi, H. (2006). HIV-1 anti-retroviral drug effect on the C. albicans hyphal growth rate by a bio-cell tracer system. Braz. J. Microbiol., 37, 225-229.         [ Links ]

 

 

Submitted: March 23, 2007; Returned to authors for corrections: July 22, 2007; Approved: November 15, 2007.

 

 

* Corresponding Author. Mailing address: Departamento de Química – ICEx – UFMG – Av. Antonio Carlos, 6627, CEP 31270-901, Belo Horizonte, MG, Brasil. Tel.: +5531 3049-5754 - +5531 3049-5700. E-mail: jat@qui.ufmg.br